KOSDAQ · Healthcare · ₩158B
₩10,200+0.99%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.8% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“매출 성장은 이어졌지만 수익성 확인이 다음 과제예요.”
In the company's words · 2026 2분기 filing